3 Review(s)

Central questions that are explored include: What are the implications for health of existing systems of pharmaceutical drug regulation? And, what do existing systems of drug regulation reveal the power of transnational pharmaceutical corporations to shape regulatory and other policies? The importance attached to considering the Irish regulatory system in its international context is reflected in the inclusion of chapters that address the implications of World Trade Organisation and EU regulatory policies and regulatory trends in Canada, Britain and Australia. By demonstrating how the analysis of pharmaceutical drug regulation can provide rich insights into the operation of power in contemporary society, this book challenges the prevailing construction of drug regulation as a sphere of 'policy without politics' and aims to contribute to the imagination of better ways of regulating medicines.